Carney J M, Cheng M S, Wu C, Seale T W
Department of Pharmacology, College of Medicine, Chandler Medical Center, University of Kentucky, Lexington 40536-0036.
J Addict Dis. 1991;10(1-2):163-77. doi: 10.1300/J069v10n01_11.
A wide variety of drugs used in medicine and on a non-prescription basis have abuse liability. However, not all psychoactive drugs have demonstrable reinforcing properties either in animal models or in humans. In order to predict the abuse liability of a compound or to understand determinants of the abuse liability, several animal testing procedures have been developed. These procedures include tests for physical dependence, tolerance, disruption of ongoing behaviors, discriminative stimulus properties, and the direct or indirect assessment of the reinforcement. While tests for the production of tolerance and physical dependence may not predict abuse liability, they would significantly modify the abuse risk. This paper will focus on the methods available for the assessment of the reinforcing properties and the advantages of using genetically defined mice to better understand the determinants of the reinforcing properties and to isolate phenotypes that are hyper-responsive and hypo-responsive to the reinforcing properties of drugs under study. Examples of genetically determined differences are provided and areas of inadequate information are discussed.
医学上使用的以及非处方类的各种各样的药物都有被滥用的可能性。然而,并非所有精神活性药物在动物模型或人类身上都具有明显的强化特性。为了预测一种化合物的滥用可能性或了解滥用可能性的决定因素,已经开发了几种动物测试程序。这些程序包括身体依赖性测试、耐受性测试、对正在进行行为的干扰测试、辨别刺激特性测试以及对强化作用的直接或间接评估。虽然耐受性和身体依赖性产生的测试可能无法预测滥用可能性,但它们会显著改变滥用风险。本文将重点介绍可用于评估强化特性的方法,以及使用基因定义的小鼠的优势,以便更好地了解强化特性的决定因素,并分离出对所研究药物的强化特性反应过度和反应不足的表型。文中提供了基因决定差异的实例,并讨论了信息不足的领域。